glp 1 agonist history Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Another milestone in the evolution

The efficacy of the tri-agonists derives from the anorectic and insulinotropic activities of GLP-1 and GIP and the energy expenditure induction of glucagon (67)

Treatment satisfaction data from patient-reported outcome studies suggest that patients are satisfied with injectable therapies if they provide advantages over orally administered treatments 84 , 85

Bottom line: Choose Tirzepatide if you want the largest expected weight-loss response and stronger glucose improvementsespecially for prediabetes/T2D and recomposition goals (with structured training and nutrition)

Monami M, Genovese S, Mannucci E

At the time we first started pursuing this litigation, Mounjaro was probably the only label that listed something related to gastroparesis, but it is in no way adequate

Adding external GLP-1either through IV at high doses or as medicationslows down stomach emptying quite a bit